Fundraising FoxLux Ventures
Venture capitalNew York
Find your way into Lux Ventures
Sign up to see every warm intro you have to Lux Ventures
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Lux Ventures team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
What they invest in
from 5 of 5 portfolio companiesDeep Tech ×3Biotech ×2Medical Devices ×2AI & Machine Learning ×1Construction Tech ×1Consumer ×1Data & Infrastructure ×1Enterprise Software ×1
HQs:United States×5
Investments · 5 tracked
founders shown can be your intro pathBy year:2020 · 22012 · 13 dated
Everspin Technologies manufactures Magnetoresistive Random Access Memory (MRAM) products for mission-critical applications requiring high reliability, low power consumption, and fast access.
Deep TechHardwareSemiconductorsChandler, US
PHILLIP LOPRESTI(Executive Officer, Director)inROBERT SCHUCH(Executive Officer)Sanjeev Aggarwal(President, Chief Executive Officer and Director)in
BoardLARRY FINCH(Director)STEPHEN SOCOLOF(Director)PETER HEBERT(Director)
Co-investorsEPIC VENTURESLux CapitalDraper Fisher Jurvetson (DFJ)GLOBALFOUNDRIES
Recursion applies computational and data-driven approaches to biological science, aiming to accelerate drug discovery and develop new treatments.
AI & Machine LearningBiotechData & InfrastructureDeep TechMedical DevicesSalt Lake City, US
Chris Gibson(Co-founder and Chairman of the Board)inBlake C. Borgeson(Executive Officer, Director)inDean Y. Yi(Executive Officer, Director)Najat Khan(Chief Executive Officer)inNajat Khan, Ph.D.(CEO and President)inBlake Borgeson(Founder)
Co-investorsDCVC (Data Collective)Lux CapitalBaillie GiffordAdvantage Capital PartnersAir Street CapitalAmplify Partners+22 more
Senti Bio develops cell and gene therapies for cancer and difficult-to-treat diseases using synthetic biology and engineered Gene Circuits to enhance precision, control, and selectivity in targeting tumor cells.
BiotechDeep TechMedical DevicesSouth San Francisco, US
Tim Lu(Co-Founder and Chief Executive Officer)inPhilip Lee(Executive Officer)inKanya Rajangam(President, Head of Research & Development and Chief Medical Officer)inYvonne Li(Executive Officer)inJames Collins(Director)Timothy Lu(Founder)
Co-investorsEvolution VC PartnersFlucas VenturesGaingelsGreen Sands EquityLifeforce CapitalLifeSci Venture Partners+13 more
__Twitter.png)
Matterport provides 3D imaging and digital twin technology for real estate, construction, facilities management, and property marketing, enabling clients to visualize spaces remotely and make data-driven decisions.
Construction TechConsumerEnterprise SoftwarePropTechSunnyvale, US
Matt Bell(Founder)inDavid Gausebeck(Chief Scientist)inMichael Beebe(COO)inRJ Pittman(CEO)inWillian Brown(Chief Executive Officer)Dave Gausebeck(Founder)
Board seatPeter Hebert· per SEC Form D · $52.4M raise · filed Jul 2020
Co-investorsBling CapitalBoxGroupBrighter CapitalCapria VenturesDCM VenturesFelicis Ventures+30 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Exits · 4
4 IPOs · showing 3EverspinNASDAQ: MRAMRecursion PharmaceuticalsNASDAQ: RXRXSenti BiosciencesNASDAQ: SNTI
Fund performance · per public LP disclosures
as of Jun 2025| Fund | Vintage | Committed | Net IRR | TVPI | DPI |
|---|---|---|---|---|---|
| Lux Ventures VIII, L.P.LPs: California Public Employees' Retirement System | 2023 | — | — | 1.41x | 0.00x |
Source: public limited-partner disclosures (CalPERS, CalSTRS). Net IRR / TVPI / DPI as reported by the limited partner; a fund's early-year IRR is an interim estimate (J-curve).
IPO stake values · per SEC filings · 2
Value of this firm's stake in each portfolio company at its IPO price, from the prospectus principal-stockholder table.
| Company | Owned | IPO price | At IPO | Stake value |
|---|---|---|---|---|
| Recursion Pharmaceuticals | 11.3% | $18.00 | Apr 2021 | $309.4M |
| Everspin | 7.0% | $8.00 | Oct 2016 | $7M |
Source: SEC S-1 / 424B prospectus filings. Stake value = shares beneficially owned × the initial public offering price, as disclosed — a market value at IPO, not a return multiple (the firm's original cost is not disclosed).
Frequently asked questions
- How many investments has Lux Ventures made?
- Lux Ventures has 5 tracked investments, 4 of which have exited.
- Where is Lux Ventures located?
- Lux Ventures is headquartered in New York, US.